ACH analyst estimates
Accendra Health (ACH) analyst ratings, the average price target and its range, and every firm's latest call.
- 4 firms rate ACH: 1 buy, 3 hold, 0 sell.
- The average price target is $1.50 from None analysts, from $1.50 to $1.50.
ACH analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 13, 2026 | UBS | Accendra Health price target lowered to $1.50 from $4.50 at UBS | $1.50 |
| Aug 11, 2026 | Robert W. Baird | Baird Downgrades Accendra Health Inc. (ACH) to Neutral | $1.50 |
| May 12, 2026 | Robert W. Baird | Accendra Health price target raised to $6 from $5 at Baird | $6.00 |
| May 12, 2026 | UBS | Accendra Health price target raised to $4.50 from $3 at UBS | $4.50 |
| Feb 22, 2026 | UBS | Accendra Health price target lowered to $3 from $4 at UBS | $3.00 |
| Jan 6, 2026 | Robert W. Baird | Accendra Health price target lowered to $5 from $7 at Baird | $5.00 |
| Nov 3, 2025 | UBS | UBS Downgrades Owens & Minor (OMI) to Neutral | $4.00 |
| Aug 13, 2025 | UBS | Owens & Minor price target lowered to $7 from $13 at UBS | $7.00 |
| Aug 11, 2025 | J.P. Morgan | Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings | $10.00 |
| Aug 8, 2025 | Robert W. Baird | Owens & Minor upgraded to Outperform from Neutral at Baird | $10.00 |
| Nov 5, 2024 | Robert W. Baird | Owens & Minor (OMI) PT Lowered to $14 at Baird | $14.00 |
| Sep 23, 2024 | Robert W. Baird | Baird Reiterates Neutral Rating on Owens & Minor (OMI) | $19.00 |
| Jun 25, 2024 | Robert W. Baird | Owens & Minor price target lowered to $20 from $24 at Baird | $20.00 |
| Jun 25, 2024 | Leerink Partners | Owens & Minor price target lowered to $17 from $21 at Leerink | $17.00 |
| May 6, 2024 | Robert W. Baird | Owens & Minor (OMI) PT Lowered to $24 at Baird | $24.00 |